DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--
The "Global Companion Diagnostics Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.
Market Outlook
Based on this report, the global companion diagnostics market is projected to progress with a CAGR of 12.84% during the forecast period 2022-2028.
The prominent factors fueling the global market's growth include a surge in medication reaction incidence, increasing cancer cases, and the growing use of precision medicines. Additionally, the ongoing research and investments in next generation gene-sequencing are expected to create affluent opportunities for the market.
However, a weak reimbursement framework and common cases of leakage in oncology companion diagnostics are expected to restrict the studied market's growth over the forecast period.
Regional Outlook
The global companion diagnostics market covers North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.
The Asia-Pacific is anticipated to emerge as the fastest-growing region over the forecast period. The region's growth can be attributed to the tremendous growth in precision medicine technology. Moreover, initiatives undertaken to promote the R&D of precision medicine are supporting the market's growth. In this regard, diagnostic and pharma companies are collaborating to offer an international platform to facilitate access to precision medicine. Thus, as mentioned above, these factors are expected to widen the scope and growth of the companion diagnostics market in the upcoming years.
Market Dynamics
Market Drivers
Market Challenges
Market Opportunity
Key Topics Covered:
1. Global Companion Diagnostics Market - Summary
2. Industry Outlook
3. Global Companion Diagnostics Market Outlook - by Mechanism
4. Global Companion Diagnostics Market Outlook - by Indicator
5. Global Companion Diagnostics Market Outlook - by Consumer
6. Global Companion Diagnostics Market Outlook - by Commodity
7. Global Companion Diagnostics Market - Regional Outlook
8. Competitive Landscape
9. Research Methodology & Scope
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/jqbmgd
View source version on businesswire.com:https://www.businesswire.com/news/home/20220930005326/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/30/2022 08:30 AM/DISC: 09/30/2022 08:32 AM
http://www.businesswire.com/news/home/20220930005326/en